Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trial

ABSTRACT

Objectives: To assess the level of homocysteine (tHcy) in children taking AEDs and to study whether daily oral supplementation of folic acid for 1 month will reduce the tHcy level. Materials and Methods: This was a double-blinded, randomized control trial conducted in Institute of Maternal and Child Health, Kozhikode, India. Totally 60 children were recruited and of them, 48 were enrolled. Of these children, 32 were assigned to the experimental group and 16 to the control group. Baseline data collection and tHcy estimation were done. One mg folic acid tablets were given to the experimental group and placebo tablets to the control group for 30 days. tHcy levels were re-estimated after 1 month follow-up. Statistical significance was tested by χ2 test, and paired and unpaired t-tests, as appropriate. Correlation was tested by Pearson correlation test and P value less than 0.05 was taken as the cut-off for statistical significance. Results: Baseline plasma tHcy concentrations in both groups were comparable [11.90 (6.3) and 13.02 (2.4) µmol/l, respectively]. During the follow-up period, no increase in seizure episodes or no serious adverse reactions were noticed in either group. The reduction of tHcy in the experimental group was 1.92 µmol/l (P = 0.04) and in the control group, there was an increase of 1.05 µmol/l (P = 0.16). Conclusions: In children on AED treatment, folic acid supplementation may reduce tHcy level and thus reduce CVD risk.

KEYWORDS

• Antiepileptic drugs
• cardiovascular disease risk factors
• folic acid supplementation
• hyperhomocysteinemia

Showing references and in-text citations exactly as published.

Cite this article

• DOI10.4103/0976-500X.130048Copy

RELATED ARTICLES

Matched on section and article type within this issue of J Pharmacol. Pharmacother..

• Article · VOLUME 5, ISSUE 2Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reportsIlma Bertulyte, Sofie Schwan, Pär Hallberg · pp. 100–138Research PaperSame type: Article
• Article · VOLUME 5, ISSUE 2Assessment of demographics, treatment strategies, and evidence‑based medicine use among diabetic and non‑diabetic patients with acute coronary syndrome: A cohort studyBhavik S. Shah, Shrikalp S. Deshpande · pp. 139–144Research PaperSame type: Article
• Article · VOLUME 5, ISSUE 2Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosisKalpesh Jain, Mira Desai, Rajesh Solanki, Ram Kumar Dikshit · pp. 145–149Research PaperSame type: Article
• Article · VOLUME 5, ISSUE 2Informed Consent on CameraSmita Sontakke, Parag Kinge · pp. 150–151Same type: Article